Chemotherapy combined with an ALK DNA vaccine was additionally found to have a synergistic effect on inhibiting tumor growth in vivo and improving survival in mice, while the results of the study found that this ALK vaccine could double the survival of mice with ALK positive NSCLC and reduce the number of tumor cells by 60% (120, 121). This evidence concerns the gene ALK and neoplasm.